AB vs FHI

The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score, raising concerns about bankruptcy risk assessment. Despite a high dividend yield of 8.73%, the payout ratio of 111.92% is unsustainable, supported by negative profit margin and declining revenue. Valuation appears stretched relative to intrinsic metrics, with the stock trading at $38.96 versus a Graham Number of $29.35 and intrinsic value of $20.72. Negative insider sentiment, deteriorating growth trends, and weak technicals further reinforce a bearish outlook.

FHI exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an exceptional ROE of 34.30%, indicating high operational efficiency. While the stock trades significantly below its growth-based intrinsic value ($151.34), it is currently priced above its defensive Graham Number ($43.53). The bullish fundamental profile is heavily countered by bearish insider sentiment (12 sell transactions) and a very weak technical trend (10/100). Consequently, the stock is a fundamental value play currently lacking market momentum and internal confidence.